Malignant Neoplasms of Lip Oral Cavity and Pharynx Recruiting Phase 1 Trials for Paclitaxel (DB01229)

IndicationStatusPhase
DBCOND0081505 (Malignant Neoplasms of Lip Oral Cavity and Pharynx)Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03430882Sapanisertib, Carboplatin, and Paclitaxel in Treating Patients With Recurrent or Refractory Malignant Solid TumorsTreatment